n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with piroxicam in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 14 (60.87) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, A; Ino, N; Mori, H; Niwa, M; Yoshimi, N | 1 |
| Harada, Y; Hatanaka, K; Katori, M; Kawamura, M; Ogino, K | 1 |
| Auguet, M; Chabrier, PE; Zerrouk, A | 1 |
| Gilroy, DW; Tomlinson, A; Willoughby, DA | 1 |
| Catalioto, RM; Criscuoli, M; Cucchi, P; Lecci, A; Maggi, CA; Meini, S | 1 |
| Gilroy, DW; Greenslade, K; Seed, MP; Tomlinson, A; Willoughby, DA | 1 |
| Hunter, JC; Lashbrook, JM; Ossipov, MH; Porreca, F; Raffa, RB; Tallarida, RJ | 1 |
| Langenbach, R; Morham, SG; Young, DA; Zhang, X | 1 |
| Dwyer, JE; Gross, JM; Knox, FG | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Chan, PH; Goldsteins, G; Huang, CY; Koistinaho, J; Salminen, A; Vartiainen, N | 1 |
| Bellot, JL; Castillo, M; García-Cabanes, C; Orts, A; Palmero, M | 1 |
| Bugajski, AJ; Bugajski, J; Gadek-Michalska, A; Głód, R | 1 |
| Du, W; Eisenach, JC; Ma, W | 1 |
| Bugajski, AJ; Bugajski, J; Gadek-Michalska, A | 2 |
| Bode, AM; Dong, Z; Liu, G; Ma, WY; Zhang, Y | 1 |
| Bugajski, AJ; Bugajski, J; Gadek-Michalska, A; Głód, R; Thor, P | 1 |
| Kaminski, NE; Rockwell, CE | 1 |
| Lee, CH; Lui, PW | 1 |
| Bugajski, J; Gadek-Michalska, A | 1 |
| Grosman, N | 1 |
| Hirate, K; Irifune, M; Ishida, T; Nakamura, N; Nishikawa, T; Sato, T; Tanaka, K | 1 |
23 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and piroxicam
| Article | Year |
|---|---|
Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Ibuprofen; Indomethacin; Isoenzymes; Membrane Proteins; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Tumor Cells, Cultured | 1997 |
Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Gastric Mucosa; In Vitro Techniques; Indomethacin; Isoenzymes; Male; Meloxicam; Membrane Proteins; Nitrobenzenes; Piroxicam; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides; Therapeutic Equivalency; Thiazines; Thiazoles | 1997 |
Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cycloheximide; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium, Vascular; Enzyme Induction; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Synthesis Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Time Factors; Vasoconstrictor Agents | 1998 |
Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Male; Membrane Proteins; Nitrobenzenes; Piroxicam; Pleural Effusion; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides | 1998 |
Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Topics: Animals; Bradykinin; Cystitis; Dinoprostone; In Vitro Techniques; Ketoprofen; Male; Muscle Contraction; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Sulfonamides; Urinary Bladder | 1998 |
The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Bone and Bones; Cartilage, Articular; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Isoenzymes; Male; Mycobacterium tuberculosis; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides | 1998 |
Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats.
Topics: Analgesics, Opioid; Animals; Cyclooxygenase Inhibitors; Drug Synergism; Hyperalgesia; Injections, Spinal; Isoenzymes; Ketorolac; Male; Morphine; Neuralgia; Nitrobenzenes; Pain Threshold; Piroxicam; Rats; Rats, Sprague-Dawley; Spinal Nerves; Sulfonamides; Tolmetin | 1999 |
Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arachidonic Acid; Cell Line; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Embryo, Mammalian; Fibroblasts; Ibuprofen; Indomethacin; Isoenzymes; Membrane Proteins; Mice; Mice, Knockout; Nitrobenzenes; Oncogene Proteins, Viral; Piroxicam; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Simian virus 40; Sulfonamides; Sulindac | 1999 |
Natriuretic response to increased pressure is preserved with COX-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Isoenzymes; Kidney; Male; Meloxicam; Natriuresis; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazines; Thiazoles | 1999 |
The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Drinking; Endotoxins; Feeding and Eating Disorders; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Sialoglycoproteins; Sulfonamides | 2000 |
Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition.
Topics: Animals; Cell Hypoxia; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; Cytoprotection; Electrophoretic Mobility Shift Assay; Hypoxia, Brain; Immunohistochemistry; L-Lactate Dehydrogenase; Neurons; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Spinal Cord; Sulfonamides | 2001 |
Inhibition of COX in ocular tissues: an in vitro model to identify selective COX-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Endothelium, Corneal; Isoenzymes; Lipopolysaccharides; Nitrobenzenes; Pigment Epithelium of Eye; Piroxicam; Prostaglandin-Endoperoxide Synthases; Salmonella typhimurium; Sulfonamides | 2001 |
Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses.
Topics: Adrenocorticotropic Hormone; Animals; Clonidine; Corticosterone; Cyclooxygenase 1; Cyclooxygenase 2; Hypothalamo-Hypophyseal System; Isoenzymes; Isoproterenol; Male; Membrane Proteins; Nitric Oxide; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Receptors, Adrenergic; Stress, Psychological; Sulfonamides | 2001 |
Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Ketorolac; Ligation; Mechanoreceptors; Nerve Tissue Proteins; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Sciatic Nerve; Spinal Cord; Sulfonamides | 2002 |
Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress.
Topics: Adrenal Cortex; Animals; Carbachol; Cholinergic Agonists; Crowding; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hypothalamo-Hypophyseal System; Indomethacin; Isoenzymes; Male; Membrane Proteins; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptors, Muscarinic; Stress, Psychological; Sulfonamides | 2002 |
NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2.
Topics: Animals; Blotting, Western; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Luciferases; MAP Kinase Kinase 4; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase Kinases; Nitrobenzenes; Phosphorylation; Piroxicam; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor AP-1; Transcription Factors; Ultraviolet Rays | 2003 |
Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Corticotropin-Releasing Hormone; Crowding; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hypothalamo-Hypophyseal System; Isoenzymes; Male; Membrane Proteins; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Sulfonamides | 2003 |
Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic - pituitary - adrenal axis.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Administration Schedule; Histamine; Histamine Agonists; Hypothalamo-Hypophyseal System; Indomethacin; Injections, Intraperitoneal; Injections, Intraventricular; Isoenzymes; Male; Membrane Proteins; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides; Thiazoles | 2003 |
A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Topics: Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; Benzamides; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Female; Flurbiprofen; Interleukin-2; Isoenzymes; Mice; Nitrobenzenes; Piroxicam; Polyunsaturated Alkamides; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonamides | 2004 |
Preemptive effects of intrathecal cyclooxygenase inhibitor or nitric oxide synthase inhibitor on thermal hypersensitivity following peripheral nerve injury.
Topics: Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitrobenzenes; Pain; Pain Threshold; Piroxicam; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sulfonamides | 2004 |
Role of prostaglandins and nitric oxide in the lipopolysaccharide-induced ACTH and corticosterone response.
Topics: Adrenocorticotropic Hormone; Animals; Arginine; Corticosterone; Cyclooxygenase Inhibitors; Guanidines; Hypothalamo-Hypophyseal System; Indomethacin; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandins; Rats; Rats, Wistar; Sulfonamides | 2004 |
Comparison of the influence of NSAIDs with different COX-selectivity on histamine release from mast cells isolated from naïve and sensitized rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Furans; Histamine Release; Horses; Male; Mast Cells; Meloxicam; Nitrobenzenes; p-Methoxy-N-methylphenethylamine; Piroxicam; Rats; Rats, Wistar; Serum; Sulfonamides; Thiazines; Thiazoles | 2007 |
Inhibitory effect of cyclooxygenase inhibitors on the step-through passive avoidance performance in mice treated with NC-1900, an arginine-vasopressin fragment analog.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Behavior, Animal; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Indomethacin; Male; Memory; Mice; Mice, Inbred Strains; Nitrobenzenes; Oligopeptides; Piroxicam; Pyrrolidonecarboxylic Acid; Sulfonamides | 2007 |